• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

MUMBAI: Sun Pharmaceutical Industries Ltd has posted a net profit of Rs 80.72 crore, up 14.6 per cent, for the three-month period ended December 31, 2004.

This profit was after a one-time management fee of Rs 15.7 crore, in connection with the issue of foreign currency convertible bonds and higher research and development expense, a company note said. Total income at Rs 352.69 crore was up 30.4 per cent in the period under review.

Sun Pharma posted a consolidated net profit of Rs 109.95 crore, up 25.1 per cent, for the third quarter. It also clocked a total income of Rs 352.66 crore, up 27 per cent, from the same period in the previous year.

The company is slated to hold an extraordinary general meeting on February 8 for consideration of appointment of Deloitte Haskins & Sells as statutory auditors, to fill the casual vacancy created on the resignation of the existing auditor.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
EID Parry profit zooms

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line